Notice of Availability of Frequently Asked Questions for PAR-16-301 "Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24)"

Notice Number: NOT-HL-16-449

Key Dates
Release Date: September 20, 2016

Related Announcements
PAR-16-301
NOT-HL-16-321

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice to inform potential applicants that NHLBI has posted a set of answers to Frequently Asked Questions (FAQs) regarding application for PAR-16-301 "Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24)".

The Frequently Asked Questions are available at this site:

PAR-16-301 Frequently Asked Questions

In addition, information on NHLBI Research Support Mechanisms for Clinical Trials is available at:

NHLBI Research Support Mechanisms Guidelines and Descriptions

While not required, all applicants are encouraged to view the FAQs prior to submitting their application.

Inquiries

Please direct all inquiries to:

Email: [email protected]